$15www.pharmatechoutlook.comMAY - 01 - 2025ISSN 2644-2787ACTO TechnologiesA New Frontier for GenAI in Life SciencesTOPVEEVA AI SOLUTIONSPROVIDER2025Kapil Kalra,Chief Revenue OfficerAlison Muller,Chief Marketing OfficerParth Khanna,Chief Executive OfficerJenny Yeung,Chief Finance OfficerKumar Erramilli,Co-founder andChief Technology Officer
Page 2 >